Literature DB >> 16531555

Decrease of regulatory T cells in patients with systemic lupus erythematosus.

S Mellor-Pita, M J Citores, R Castejon, P Tutor-Ureta, M Yebra-Bango, J L Andreu, J A Vargas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16531555      PMCID： PMC1798083          DOI： 10.1136/ard.2005.044974

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  9 in total

Review 1.  Regulatory T cells in autoimmmunity*.

Authors:  E M Shevach
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

4.  Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.

Authors:  S Sakaguchi; N Sakaguchi; M Asano; M Itoh; M Toda
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

5.  Quantification of regulatory T cells in patients with systemic lupus erythematosus.

Authors:  Jose C Crispin; Araceli Martínez; Jorge Alcocer-Varela
Journal:  J Autoimmun       Date:  2003-11       Impact factor: 7.094

Review 6.  T cells in the pathogenesis of systemic lupus erythematosus.

Authors:  Robert W Hoffman
Journal:  Clin Immunol       Date:  2004-10       Impact factor: 3.969

7.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

8.  Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus.

Authors:  M-F Liu; C-R Wang; L-L Fung; C-R Wu
Journal:  Scand J Immunol       Date:  2004-02       Impact factor: 3.487

Review 9.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527
  9 in total
  32 in total

1.  Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  J Immunol       Date:  2014-03-28       Impact factor: 5.422

Review 2.  Natural regulatory T cells in autoimmunity.

Authors:  Elaine V Lourenço; Antonio La Cava
Journal:  Autoimmunity       Date:  2010-11-23       Impact factor: 2.815

3.  IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cells.

Authors:  Masayuki Mizui; Tomohiro Koga; Linda A Lieberman; Jessica Beltran; Nobuya Yoshida; Mark C Johnson; Roland Tisch; George C Tsokos
Journal:  J Immunol       Date:  2014-07-25       Impact factor: 5.422

Review 4.  TLR7 and TLR9 in SLE: when sensing self goes wrong.

Authors:  T Celhar; R Magalhães; A-M Fairhurst
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

5.  Blockade of Treg Cell Differentiation and Function by the Interleukin-21-Mechanistic Target of Rapamycin Axis Via Suppression of Autophagy in Patients With Systemic Lupus Erythematosus.

Authors:  Hiroshi Kato; Andras Perl
Journal:  Arthritis Rheumatol       Date:  2018-01-30       Impact factor: 10.995

6.  T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus.

Authors:  Matthew J Loza; A Shane Anderson; Kenneth S O'Rourke; James Wood; Islam U Khan
Journal:  Cell Immunol       Date:  2011-07-18       Impact factor: 4.868

7.  Regulatory T cells and their role in rheumatic diseases: a potential target for novel therapeutic development.

Authors:  Diana Milojevic; Khoa D Nguyen; Diane Wara; Elizabeth D Mellins
Journal:  Pediatr Rheumatol Online J       Date:  2008-12-01       Impact factor: 3.054

8.  The peroxisome-proliferator activated receptor-γ agonist pioglitazone modulates aberrant T cell responses in systemic lupus erythematosus.

Authors:  Wenpu Zhao; Celine C Berthier; Emily E Lewis; W Joseph McCune; Matthias Kretzler; Mariana J Kaplan
Journal:  Clin Immunol       Date:  2013-07-20       Impact factor: 3.969

9.  Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus.

Authors:  L Ma; P Zhao; Z Jiang; Y Shan; Y Jiang
Journal:  Clin Exp Immunol       Date:  2013-12       Impact factor: 4.330

10.  Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus.

Authors:  Li Zhang; Anne M Bertucci; Rosalind Ramsey-Goldman; Richard K Burt; Syamal K Datta
Journal:  J Immunol       Date:  2009-10-19       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.